Clinical trial
Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism
NCT00282412 · Northwestern University, Other · Terminated
Key facts
| NCT number | NCT00282412 |
|---|---|
| Title | Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism |
| Official title | Rheumatoid Arthritis: Tolerance Induction by Mixed Chimerism |
| Lead sponsor | Northwestern University, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Biological, Drug |
| Interventions | Hematopoietic Stem Cell Transplantation, Fludarabine, Cyclophosphamide, Campath 1H, GCSF, Cyclosporins, Mycophenolate Mofetil |
| Enrollment | 4 |
| Start date | Sep 1, 2002 |
| Primary completion | Jun 1, 2016 |
| Completion | Jun 1, 2016 |
| First posted | Jan 26, 2006 |
| Last update posted | Jul 30, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: